Showing 1 - 3 results of 3 for search 'Muhasaparur Ganesan Rajanandh', query time: 0.02s Refine Results
  1. 1
    Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19

    Siltuximab - A monoclonal antibody against the interleukin-6 receptor is not an ideal option for management of COVID-19 by I Jerlin Michelle, S A Shevaani, Kiran Kumar Rathinam, Justin Jacob Abraham, Muhasaparur Ganesan Rajanandh, Thangavel Mahalingam Vijayakumar

    Published 2021-01-01
    Get full text
    Article
  2. 2
    Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19

    Tolerability of Sarilumab – An anti-interleukin-6 receptor monoclonal antibody is controversial for the management of COVID-19 by Justin Jacob Abraham, I Jerlin Michelle, S A Shevaani, Kiran Kumar Rathinam, Muhasaparur Ganesan Rajanandh, Vijayakumar Thangavel Mahalingam

    Published 2021-01-01
    Get full text
    Article
  3. 3
    Barriers of healthcare professionals in utilizing the service of drugs and poison information Centre: A cross-sectional study

    Barriers of healthcare professionals in utilizing the service of drugs and poison information Centre: A cross-sectional study by Harini Muralidharan, Arthi Venkatesan, Rishitha Venati, Indrani Devi Dhanasekaran, Teshini Suthahar, Abrar Ahmed, Arushi Salhotra, Bijisha Baburaj Nair, Mohana Krishnan, Muhasaparur Ganesan Rajanandh

    Published 2022-06-01
    Get full text
    Article

Search Tools: